Genetics, ethanol and the Fos response: A comparison of the C57BL/6J and DNA/2J inbred mouse strains

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 8, 1997, Pages 1497-1507

  Hitzemann, Barbara ^a,b   Hitzemann, Robert ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Amygdala; Basal Ganglia; C Fos; Dopamine; Ethanol

Indexed keywords

ALCOHOL; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; MUSCIMOL;

ALCOHOL CONSUMPTION; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN; CONTROLLED STUDY; DOPAMINE RELEASE; ENTOPEDUNCULAR NUCLEUS; GLOBUS PALLIDUS; LIMBIC CORTEX; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PUTAMEN; STRAIN DIFFERENCE; SUBSTANTIA NIGRA; THALAMUS NUCLEUS;

EID: 0030657781     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb04482.x     Document Type: Article

References (73)

1. Crabbe JC, Johnson NA, Gray DK, Kosobud A, Young ER: Biphasic effects of ethanol on open field activity: Sensitivity and tolerance to C57BL/6N and DBA/2N mice. J Comp Physiol Psychol 96:440-451, 1982
2. Crabbe JC: Genetic differences in locomotor activation in mice. Pharmacol Biochem Behav 25:289-292, 1986
3. Dudek BC, Phillips TJ: Distinctions among sedative, disinhibitory, and ataxic properties of ethanol in inbred and selectively bred mice. Psychopharmacology 101:93-99, 1990
4. Dudek BC, Phillips TJ, Hahn ME: Genetic analyses of the biphasic nature of the alcohol dose-response curve. Alcohol Clin Exp Res 15:262-269, 1991
5. Dudek BC, Tritto T: Biometrical genetic analysis of ethanol's psychomotor stimulant effect. Alcohol Clin Exp Res 18:956-963, 1994
6. Liljequist S, Berggren U, Engel J: The effect of catecholamine receptor antagonists on ethanol-induced locomotor stimulation. J Neural Transm 50:57-67, 1981
7. Risinger FO, Dickinson SD, Cunningham CL: Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference. Psychopharmacology 107:453-456, 1992
8. Broadbent J, Grahame NJ, Cunningham CL: Haloperidol prevents ethanol-stimulated locomotor activity but fails to block sensitization. Psychopharmacology 120:475-482, 1995
9. Shen EH, Crabbe JC, Phillips TJ: Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice. Psychopharmacology 118:28-36, 1995
10. Blomqvist O, Engel JA, Nissbrandt H, Soderpalm B: The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Eur J Pharmacol 249:207-213, 1993
11. Brodie MS, Shefner SA, Dunwiddie TV: Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro. Brain Res 508:65-69, 1990
12. Brodie MS, Trifunovic RD, Shefner SA: Serotonin potentiates ethanol-induced excitation of ventral tegmental neurons in brain slices from three different rat strains. J Pharmacol Exp Ther 273:1139-1146, 1995
13. Trifunovic RD, Brodie MS: The effects of clomipramine in the excitatory action of ethanol on dopaminergic neurons of the ventral tegmental area in vitro. J Pharmacol Exp Ther 276:34-40, 1996
14. Milton GV, Randall PK, Erickson CK: Low-dose effect of ethanol on locomotor activity induced by activation of the mesolimbic system. Alcohol Clin Exp Res 19:768-776, 1995
15. Erwin VG, Su NC: Neurotensin and ethanol interactions on hypothermia and locomotor activity in LS and SS mice. Alcohol Clin Exp Res 13:91-94, 1989
16. Erwin VG, Jones BC: Genetic correlations among ethanol-related behaviors and neurotensi receptors in long sleep (LS) × short sleep (SS) recombinant inbred strains of mice. Behav Genet 23:191-196, 1993
17. Erwin VG, Jones BC, Myers R: Effects of acute and chronic ethanol administration on neurotensinergic systems. Ann NY Acad Sci 739:185-196, 1994
18. 2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. J Pharmacol Exp Ther 267:538-547, 1993
19. McCaughran JA Jr, Cipp L, Ramphir N, Mahjubi E, Hitzemann R: QTL analysis of ethanol-induced activation: A preliminary report. Alcohol Clin Exp Res 21:67, 1997
20. Hitzemann R, Qian Y, Kanes S, Dains K, Hitzemann B: Genetics and the organization of the basal ganglia. Int Rev Neurobiol 38:43-94, 1995
21. Gerfen CR: The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia. Ann Rev Neurosci 15:285-320, 1992
22. Morgan JI, Cohen DR, Hempstead JL, Curran T: Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237:192-197, 1987
23. Morgan JI, Curran T: Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun. Ann Rev Neurosci 14:421-451, 1991
24. Ryabinin AE, Melia KR, Cole M, Bloom FE, Wilson MC: Alcohol selectively attenuates stress-induced c-fos expression in rat hippocampus. J Neurosci 15:721-730, 1995
25. Ryabinin AE, Criado JR, Henrikson SJ, Bloom FE, Wilson MC: Differential sensitivity of c-fos expression in hippocampus and other brain regions to moderate and low doses of ethanol. Mol Psychol 2:32-43, 1996
26. Chang SL, Patel NA, Romero AA: Activation and desensitization of fos immunoreactivity in the rat brain following ethanol administration. Brain Res 679:89-98, 1995
27. Davidson M, Matsumoto I, Shanely BC, Wilce PA: Fos and jun as markers for ethanol-sensitive pathways in the rat brain. Brain Res Bull 39:177-184, 1996
28. Melia KR, Ryabinin AE, Corodimas KP, Wilson MC, LeDoux JE: Hippocampal-dependent learning and experience-dependent activation of the hippocampus are preferentially disrupted by ethanol. Neuroscience 74:313-322, 1996
29. Alheid GF, de Olmos JS, Beltramino CA: Amygdala and extended amygdala, in Paxinos G (ed): The Rat Nervous System, ed 2. San Diego, Academic Press, 1995, pp 495-578
30. Chan RKW, Sawchenko PE: Hemodynamic regulation of tyrosine hydroxylase messenger RNA in medullary catecholamine neurons: A c-fos guided hybridization histochemical study. Neuroscience 66:377-390, 1995
31. Franza BR, Sambucetti LC, Cohen DR, Curran T: Analysis of fos protein complexes and fos-related antigens by high resolution two-dimensional gel electrophoresis. Oncogene 1:213-221, 1987
32. Franza BR, Rauscher FJ, Josephs SF, Curran T: The fos complex and fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 239:1150-1153, 1988
33. Sonnenberg JL, Mitchelmore C, MacGregor-Leon PF, Hempstead J, Morgan JI, Curran T: Glutamate receptor agonists increase the expression of fos, Fra and AP-1 DNA binding activity in mammalian brain. J Neurosci Res 24:72-80, 1989
34. 2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37:287-294, 1990
35. Dilts RP, Helton TE, McGinty JE: Selective induction of fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields. Synapse 13:251-263, 1993
36. Blanchard BA, Steindorf S, Wang S, Glick SD: Sex differences in ethanol-induced dopamine release in nucleus accumbens and in ethanol consumption in rats. Alcohol Clin Exp Res 7:698-973, 1993
37. Dichara G, Imperato A: Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol 115:131-132, 1985
38. Wozniak KM, Pert A, Mele A, Linnoila M: Focal application of alcohol elevates extracellular dopamine in rat brain: A microdialysis study. Brain Res 540:31-40, 1991
39. Yoshimoto K, McBride WJ, Lumeng L, Li TK: Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 9:17-22, 1992
40. Blanchard BA, Glick SD: Sex differences in mesolimbic dopamine responses to ethanol and relationship to ethanol intake in rats, in Galanter M (ed): Recent Developments in Alcoholism, Volume 12: Women and Alcoholism. New York, Plenum Press, 1995, pp 231-241
41. Robertson HA, Paul ML, Moratalla R, Graybiel AM: Expression of the immediate early gene c-fos in basal ganglia: Induction by dopaminergic drugs. Can J Neurol Sci 18:380-383, 1991
42. Young ST, Porrino LJ, Iadarola MJ: Cocaine induces striatal c-fos immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci USA 88:1291-1295, 1991
43. Moratalla R, Xu M, Tonegawa S, Graybiel AM: Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci USA 93:14928-14933, 1996
44. Robertson GS, Jian M: D1 and D2 dopamine receptors differentially increase fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience 64:1019-1034, 1995
45. Wirtshafter D, Asin KE: Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum. Brain Res Bull 35:85-91, 1994
46. Patel N, Hitzemann B, Hitzemann R: Haloperidol, genetics and the c-fos response. Soc Neurosci Abstr 788.1, 1996
47. Ruskin DN, Marshall JF: Amphetamine and cocaine-induced fos in the rat striatum depends on D2 dopamine receptor activation. Synapse 18:233-240, 1994
48. Gerfen CR, Keefe KA, Gauda EB: D1 and D2 dopamine receptor function in the striatum: Coactivation of D1 and D2-dopamine receptors in separate populations of neurons results in potentiated immediate early gene response in D1 containing neurons. J Neurosci 15:8167-8176, 1995
49. Keefe KA, Gerfen CR: D1-D2 dopamine receptor synergy in striatum: Effects of intrastriatal infusions of dopamine agonists and antagonists in immediate early gene expression. Neuroscience 66:903-913, 1995
50. Deitrich RA, Dunwiddie TV, Harris RA, Erwin VG: Mechanism of action of ethanol: Initial central nervous system actions. Pharmacol Rev 41:489-537, 1989
51. Konradi C, Leveque JC, Hyman SE: Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on post-synaptic NMDA receptors and calcium. J Neurosci 16:4231-4239, 1996
52. Torres G, Rivier C: Cocaine-induced expression of striatal c-fos is inhibited by NMDA receptor antagonists. Brain Res Bull 30:173-176, 1993
53. Zahm DS, Brog JS: On the significance of subterritories in the "accumbens" part of the ventral striatum. Neuroscience 50:751-767, 1992
54. Heimer L, Zahm DS, Alheid GF: Basal ganglia, in Paxinos G (ed): The Rat Nervous System, ed 2. San Diego, Academic Press, 1995, pp 579-628
55. Hitzemann B, Dains K, Kanes S, Hitzemann R: Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy. J Pharmacol Exp Ther 271:969-976, 1994
56. Cohen BM, Wan W: The thalamus as a site of action for antipsychotic drugs. Am J Psychiatry 153:104-106, 1996
57. Deutch AY, Ongur D, Duman RS: Antipsychotic drugs induce fos protein in the thalamic paraventricular nucleus: A novel locus of antipsychotic drug action. Neuroscience 66:337-346, 1995
58. Berendse HW, Groenewegen HJ: Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J Comp Neurol 299:187-228, 1990
59. Price JL: Thalamus, in Paxinos G (ed): The Rat Nervous System, ed 2. San Diego, Academic Press, 1995, pp 629-648
60. Davis M, Rainnie D, Cassell M: Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 17:208-214, 1994
61. Sun N, Cassell MD: Intrinsic GABAergic neurons in the rat central extended amygdala. J Comp Neurol 330:381-404, 1993
62. McDonald AJ: Cytoarchitecture of the central amygdaloid nucleus in the rat. J Comp Neurol 208:401-408, 1982
63. McDonald AJ: Neurons of the bed nucleus of the stria terminalis: A Golgi study in the rat brain. Brain Res Bull 10:111-120, 1983
64. Arluison MF, Javoy-Agid C, Feuerstein M, Tauc M, Conrath-Verrier M, Mailly P: Histofluorescence analysis of several systems of catecholaminergic nerve fibers within the rat neostriatum revealed by either restricted lesions of the substantia nigra or gamma-hydroxybutyrate. Brain Res Bull 9:355-365, 1982
65. Hopkins DA, Holstege G: Amgydaloid projections to the mesencephalon, pons and medulla oblongata in the cat. Exp Brain Res 32:529-547, 1978
66. Gonzalez C, Chesselet M-F: Amygalonigral pathway: An anterograde study in the rat with Phaseolus vulgaris leucoagglutinin (PHA-L). J Comp Neurol 297:182-200, 1991
67. Davis M: The role of the amygdala in fear potentiated startle: Implications for animal models of anxiety. Trends Pharmacol Sci 13:35-41, 1992
68. Rassnick S, Heinrichs SC, Britton KT, Koob GF: Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605:25-32, 1993
69. Roberts AJ, Cole M, Koob GF: Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res 20:1289-1298, 1996
70. Salminen O, Lahtinen S, Ahtee L: Expression of fos protein in various rat brain areas following acute nicotine and diazepam. Pharmacol Biochem Behav 54:241-248, 1996
71. Beck CH, Fibiger HC: Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: With and without diazepam pretreatment. J Neurosci 15:709-720, 1995
72. Green S, Vale AL: Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behav Pharmacol 3:35-41, 1992
73. Pesold C, Treit D: The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 671:213-221, 1995